Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $885.17 billion, total revenue of $172.71 billion and a weighted average PE ratio of 48.93.
Market Cap
885.17B
Revenue
172.71B
Profits
18.09B
PE Ratio
48.93
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 242.11B | 0.35% | 1,667,696 | 46.34B |
| 2 | DHR | Danaher Corporation | 150.48B | 1.09% | 3,926,118 | 25.11B |
| 3 | NTRA | Natera, Inc. | 59.15B | 0.46% | 2,443,422 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 47.30B | 0.66% | 2,290,098 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 42.50B | -0.96% | 1,365,836 | 16.98B |
| 6 | WAT | Waters Corporation | 41.78B | -0.08% | 625,601 | 4.64B |
| 7 | ILMN | Illumina, Inc. | 41.23B | 2.75% | 2,833,511 | 4.49B |
| 8 | IDXX | IDEXX Laboratories, Inc. | 40.84B | 0.12% | 288,817 | 4.55B |
| 9 | MTD | Mettler-Toledo International Inc. | 29.78B | 0.34% | 131,749 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.75B | 0.97% | 1,098,305 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.02B | 1.28% | 587,428 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 23.86B | 1.75% | 1,650,736 | 1.18B |
| 13 | RVTY | Revvity, Inc. | 16.91B | 1.66% | 1,238,350 | 2.91B |
| 14 | MEDP | Medpace Holdings, Inc. | 16.73B | 0.23% | 303,676 | 2.78B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.85B | 1.17% | 445,724 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.50B | 0.11% | 676,140 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.25B | 6.45% | 4,557,460 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.40B | 8.07% | 879,205 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.50B | 3.29% | 574,188 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.20B | 0.55% | 2,223,396 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 5.00B | 0.13% | 418,070 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.52B | 3.58% | 1,575,403 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.68B | 3.67% | 1,046,210 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.47B | 1.39% | 1,593,844 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.37B | 3.88% | 2,302,423 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.18B | 3.00% | 606,659 | 454.43M |
| 27 | FRNM | Freenome, Inc. | 1.75B | 4.35% | 813,565 | 35.41M |
| 28 | PSNL | Personalis, Inc. | 1.74B | 0.68% | 1,139,089 | 69.67M |
| 29 | OPK | OPKO Health, Inc. | 1.16B | -0.64% | 1,398,968 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.09B | 0.96% | 167,717 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 591.03M | 0.85% | 297,600 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 434.25M | 11.82% | 2,289,550 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 292.48M | 1.43% | 124,289 | 102.94M |
| 34 | XGN | Exagen Inc. | 197.92M | 3.55% | 617,365 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 171.38M | 1.63% | 15,306 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 112.57M | -0.86% | 402,990 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 111.81M | -1.48% | 453,797 | 537.08K |
| 38 | MDXH | MDxHealth SA | 54.48M | -0.90% | 65,258 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 41.41M | 1.76% | 22,691 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 11.12M | -2.60% | 27,042 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 9.09M | 3.06% | 31,902 | - |
| 42 | XWEL | XWELL, Inc. | 7.20M | 2.02% | 41,197 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.27M | -1.54% | 154,565 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.72M | -5.26% | 135,123 | 466.30K |